Angiomodulin (IGFBP7) is a cerebral specific angiocrine factor, but is probably not a blood–brain barrier inducer
Open Access
- 1 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Fluids and Barriers of the CNS
- Vol. 17 (1), 1-12
- https://doi.org/10.1186/s12987-020-00188-2
Abstract
Background Several secreted factors have been identified as drivers of cerebral vasculature development and inducers of blood–brain barrier (BBB) differentiation. Vascular endothelial growth factor A (VEGF-A) is central for driving cerebral angiogenesis and Wnt family factors (Wnt7a, Wnt7b and norrin) are central for induction and maintenance of barrier properties. Expressed by developing neural tissue (neuron and glia progenitors), they influence the formation of central nervous system (CNS) vascular networks. Another type of factors are tissue-specific paracrine factors produced by endothelial cells (ECs), also known as ‘angiocrine’ factors, that provide instructive signals to regulate homeostatic and regenerative processes. Very little is known about CNS angiocrine factors and their role in BBB development. Angiomodulin (AGM) was reported to be expressed by developing vasculature and by pathological tumor vasculature. Here we investigated AGM in the developing CNS and its function as a potential BBB inducer. Methods We analyzed microarray data to identify potential angiocrine factors specifically expressed at early stages of barrier formation. We then tested AGM expression with immunofluorescence and real-time PCR in various organs during development, post-natal and in adults. Permeability induction with recombinant proteins (Miles assay) was used to test potential interaction of AGM with VEGF-A. Results Several angiocrine factors are differentially expressed by CNS ECs and AGM is a prominent CNS-specific angiocrine candidate. Contrary to previous reports, we found that AGM protein expression is specific to developing CNS endothelium and not to highly angiogenic developing vasculature in general. In skin vasculature we found that AGM antagonizes VEGF-A-induced vascular hyperpermeability. Finally, CNS AGM expression is not specific to BBB vasculature and AGM is highly expressed in non-BBB choroid-plexus vasculature. Conclusions We propose AGM as a developmental CNS vascular-specific marker. AGM is not a pan-endothelial marker, nor a general marker for developing angiogenic vasculature. Thus, AGM induction in the developing CNS might be distinct from its induction in pathology. While AGM is able to antagonize VEGF-A-induced vascular hyperpermeability in the skin, its high expression levels in non-BBB CNS vasculature does not support its potential role as a BBB inducer. Further investigation including loss-of-function approaches might elucidate AGM function in the developing CNS.Keywords
Funding Information
- German-Israeli Foundation for Scientific Research and Development (GIF I-2427-203.13-2016)
- Leona M. and Harry B. Helmsley Charitable Trust (2015PG-ISL007)
- Israel Science Foundation (1882/16)
This publication has 34 references indexed in Scilit:
- Mutation of IGFBP7 Causes Upregulation of BRAF/MEK/ERK Pathway and Familial Retinal Arterial MacroaneurysmsAmerican Journal of Human Genetics, 2011
- GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrierProceedings of the National Academy of Sciences of the United States of America, 2011
- Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptorProceedings of the National Academy of Sciences of the United States of America, 2011
- Essential Regulation of CNS Angiogenesis by the Orphan G Protein–Coupled Receptor GPR124Science, 2010
- Pericytes are required for blood–brain barrier integrity during embryogenesisNature, 2010
- Angiomodulin Is a Specific Marker of Vasculature and Regulates Vascular Endothelial Growth Factor-A–Dependent NeoangiogenesisCirculation Research, 2009
- Thrombospondin‐1 modulates vascular endothelial growth factor activity at the receptor levelThe FASEB Journal, 2009
- Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cellsEuropean Journal of Pharmacology, 2009
- Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- Wnt/β-catenin signaling controls development of the blood–brain barrierThe Journal of cell biology, 2008